RE: Double Up?23 Dec 2020 17:11
lordfurlong96 - judging by some of the recent comments here some had bought this to get exposure to Greatland Gold (GGP) similar to many investors in Starvest (SVE) and, once the PRIM's remaining holding was sold these PIs sold out of PRIM and went into GGP or SVE to continue the ride.
I'm certain that the company has a much more shareholder focused direction to it now but it will probably need buyers in their droves or a series of positive announcements to shift it in the very short term.
Looking into the new year (apart from any new investments) this could come from:
Truspine - FDA clearance is expected in Q1 2021, following which initial commercial production, marketing and early adopter surgical training will commence. I know we don't have much invested here but it could be rerated if taken out by one of its largest competitors. Not just wishful thinking - they had some analysis of the multiples achieved from spinal technology companies being snapped up.
Engage - may be bought out by a larger player before too long. It's on a path towards breakeven and funded for the next 24 to 36 months.
Zuuse - we've got a lot of these with the options as well. Looks a good investment and if I recall correctly there is a secondary market for these shares so there might be options to partial offload at a significant profit as the need arises.
SOA Energy & Nomad Energy - wouldn't surprise me if our BoD tries to get shot of these at the earliest opportunity.